| answer text |
<p>The pre-exposure prophylaxis (PrEP) Impact Trial is managed by the Trial Sponsor.
Recruitment to places in the Trial is managed locally by participating clinics. Following
funding from NHS England to pay for extra PrEP drug and research costs and the my
Rt. hon Friend the Secretary of State for Health and Social Care’s announcement on
30 January that the number of places on the PrEP Impact Trial would be doubled to
26,000, expansion of the Trial is now underway across the country. Participation in
the Trial is on a voluntary basis and it is for research clinics and local authorities
to decide whether they wish to take part and the number of allocated places they can
accept.</p><p> </p>
|
 |
